ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 826,95
0,72%
Dow Jones
44 025,81
1,24%
DAX
21 258,06
1,03%
Brent Oil
78,815
0,08%
Bitcoin
105 100,01
-1,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Shuttle Pharmaceuticals Holdings Inc (SHPH) Cours

Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings Inc (SHPH)

NASDAQ
0,88
0,04
(4,76%)
Fermé 22 Janvier 10:00PM
Retardé de 15 minutes
0,9188
0,0388
( 4,41% )
Avant marché: 10:15AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,9188
Prix Achat
0,82
Prix Vente
0,9189
Volume échangé
950
0,00 Fourchette du Jour 0,00
0,58 Plage de 52 semaines 4,7104
Cap du marché
3,367M
Clôture Veille
0,88
Ouverture
-
Dernière Transaction
148
@
0.9188
(formt)
Dernière heure de transaction
10:15:58
Volume financier
-
VWAP
-
Volume moyen (3 m)
145 684
Actions en circulation
3 664 919
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,49
Bénéfice par action (BPA)
-1,8
Chiffre d'affairess
-
Bénéfice net
-6,59M

À propos de Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surg... Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Shuttle Pharmaceuticals Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker SHPH. Le dernier cours de clôture d'Shuttle Pharmaceuticals était de US$0,88. Au cours de la dernière année, les actions de Shuttle Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,58 à US$ 4,7104.

Shuttle Pharmaceuticals compte actuellement 3 664 919 actions en circulation. La capitalisation boursière d'Shuttle Pharmaceuticals est de US$3,23 million. Shuttle Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.49.

SHPH Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

il y a 20 heures
Edgar (US Regulatory)

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

il y a 20 heures
GlobeNewswire Inc.

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

07 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

19 Décembre 2024
Edgar (US Regulatory)

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

19 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

26 Novembre 2024
Edgar (US Regulatory)

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

26 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

13 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.04485.125858123570.8740.91990.83361300.85396129CS
40.139817.9460847240.7790.94990.72655590.8501013CS
12-0.6812-42.5751.61.980.581456841.20318654CS
26-2.5268-73.33410726723.44564.160.588470771.88214556CS
52-3.4492-78.96520146524.3684.71040.585093122.15149331CS
156-191.4812-99.5224532225192.41010.080.5879649345.49203715CS
260-191.4812-99.5224532225192.41010.080.5879649345.49203715CS

SHPH - Frequently Asked Questions (FAQ)

What is the current Shuttle Pharmaceuticals share price?
The current share price of Shuttle Pharmaceuticals is US$ 0,9188
How many Shuttle Pharmaceuticals shares are in issue?
Shuttle Pharmaceuticals has 3 664 919 shares in issue
What is the market cap of Shuttle Pharmaceuticals?
The market capitalisation of Shuttle Pharmaceuticals is USD 3,23M
What is the 1 year trading range for Shuttle Pharmaceuticals share price?
Shuttle Pharmaceuticals has traded in the range of US$ 0,58 to US$ 4,7104 during the past year
What is the PE ratio of Shuttle Pharmaceuticals?
The price to earnings ratio of Shuttle Pharmaceuticals is -0,49
What is the reporting currency for Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals reports financial results in USD
What is the latest annual profit for Shuttle Pharmaceuticals?
The latest annual profit of Shuttle Pharmaceuticals is USD -6,59M
What is the registered address of Shuttle Pharmaceuticals?
The registered address for Shuttle Pharmaceuticals is 1013 CENTRE ROAD SUITE 403-B, WILMINGTON, DELAWARE, 19805
Which industry sector does Shuttle Pharmaceuticals operate in?
Shuttle Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
IPAImmunoPrecise Antibodies Ltd
US$ 0,773
(56,80%)
4,24M
CDIOCardio Diagnostics Holdings Inc
US$ 0,88
(44,74%)
6,15M
NEHCNew Era Helium Inc
US$ 3,94
(43,80%)
1,15M
ADAGAdagene Inc
US$ 2,50
(41,08%)
3
ASSTAsset Entities Inc
US$ 1,16
(28,89%)
5M
ABLAbacus Life Inc
US$ 3,01
(-59,97%)
31
HTLMHomesToLife Ltd
US$ 5,97
(-23,66%)
10
TMCITreace Medical Concepts Inc
US$ 7,23
(-22,01%)
7
ELVNEnliven Therapeutics Inc
US$ 17,21
(-21,77%)
1
VREXVarex Imaging Corporation
US$ 11,20
(-19,48%)
7
CDIOCardio Diagnostics Holdings Inc
US$ 0,88675
(45,85%)
6,16M
ASSTAsset Entities Inc
US$ 1,16
(28,89%)
5,01M
IPAImmunoPrecise Antibodies Ltd
US$ 0,79
(60,24%)
4,27M
RIMEAlgorhythm Holdings Inc
US$ 0,0381
(10,12%)
3,76M
SHViShares Short Treasury Bond ETF
US$ 110,36
(0,00%)
2,69M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SHPH
Shuttle Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés